Amlodipine And Valsartan
Pricing Report NDC 0781-5615-31

Latest NADAC: $0.45682 per EA · Effective Apr 22, 2020 · Est. package price $13.70 (30 EA)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Amlodipine And Valsartan (NDC 0781-5615-31) is $0.45682 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Apr 22, 2020.

As a provided by Sandoz Inc, this medication is distributed in a 30 TABLET, FILM COATED in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.45682
Per EA

Effective Date
Apr 22, 2020
Billable Units
30 EA
Estimated Package Price
$13.70
Data Status
As of Apr 29, 2020
C/I - Chain or Independent Pharmacy
Package NDC
Description
30 TABLET, FILM COATED in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since May 2015, the NADAC wholesale price for (NDC ) has moved within a range of $0.35316 to $4.24440 per EA. Over this 4 years and 11 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.3532 - $4.2444
Market Volatility
1,101.83% Variance
Latest Trend
0.73%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Apr 22, 2020 $0.45682 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2020 $0.46018 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 19, 2020 $0.40631 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 22, 2020 $0.42273 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 18, 2019 $0.42436 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 20, 2019 $0.41769 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 23, 2019 $0.44146 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 18, 2019 $0.42013 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Aug 21, 2019 $0.41829 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 17, 2019 $0.38210 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 19, 2019 $0.36643 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 22, 2019 $0.35799 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026